Lman2-flox Mouse
一般名
Lman2-flox
製品ID
S-CKO-13367
背景情報
C57BL/6JCya
系統ID
CKOCMP-66890-Lman2-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Lman2-flox Mouse(カタログ番号S-CKO-13367)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Lman2-flox
系統ID
CKOCMP-66890-Lman2-B6J-VA
遺伝子名
製品ID
S-CKO-13367
遺伝子別名
GP36B, VIP36, 1110003H06Rik, 1300009F09Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 13
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000021940
NCBIトランスクリプトID
NM_025828
ターゲット領域
Exon 3
有効領域の大きさ
~1.6 kb
遺伝子研究の概要
Lman2, also known as lectin, mannose-binding 2, is a cargo receptor involved in the transport and sorting of glycoproteins. It shuttles between the plasma membrane, the Golgi apparatus, and the endoplasmic reticulum, and is involved in the regulation of the MAPK signaling pathway [2,4].
In sepsis patients, high serum Lman2 levels are associated with septic shock and an unfavorable prognosis, as a high serum Lman2 level (>1.28 ng/ml) was a predictor of 28-day mortality [1]. In breast cancer, Lman2 is highly expressed compared to adjacent normal tissues, and its high expression is correlated with worse patient prognosis. Functionally, Lman2 promotes breast cancer cell proliferation, cell cycle progression, invasion, and chemoresistance while preventing apoptosis. It interacts with MAPK9 to activate the MAPK pathway and confer cisplatin resistance, and knockdown of Lman2 improves the sensitivity of drug-resistant breast cancer cells to cisplatin in vivo [2]. Also in HER2-positive breast cancer, Lman2 is overexpressed, and its knockdown suppresses cell proliferation, migration, and invasion. Lman2 interacts with HEATR3, and up-regulation of HEATR3 reverses the repressive role of Lman2 interference in the progression of HER2-positive breast cancer, Akt/ERK/NF-κB signaling, and the inflammatory response [5].
In the nervous system, Lman2 is a candidate regulatory protein that influences redox-dependent modulation of Kv1.2 channels. Co-expression with Lman2 leads to a pronounced gating shift of Kv1.2 activation to depolarized voltages, and overexpression promotes a slow gating mode of Kv1.2 that mimics the functional outcomes of extracellular reducing conditions [3]. Lman2 also competitively modulates KV1.2 gating with Slc7a5, and specific regions between the S1 to S3 segments of the voltage sensing domain of KV1.2 are distinct for either Slc7a5 or Lman2 sensitivity [6].
In Alzheimer's disease patients, the protein expression of Lman2 related to protein processing and N-glycosylation in the endoplasmic reticulum is upregulated in brain capillaries, along with ribosomal proteins [7].
In conclusion, Lman2 plays crucial roles in multiple biological processes and disease conditions. In sepsis, it is related to prognosis prediction; in breast cancer, it promotes tumorigenesis and drug resistance; in the nervous system, it regulates ion channel gating; and in Alzheimer's disease, it may be involved in protein processing changes at the blood-brain barrier. Studies on Lman2, especially through loss-of-function experiments, contribute to understanding disease mechanisms and may provide potential targets for treatment.
References:
1. Bao, Junjie, Zha, Yutao, Chen, Shi, Liu, Miao, Shao, Min. 2022. The importance of serum LMAN2 level in septic shock and prognosis prediction in sepsis patients. In Heliyon, 8, e11409. doi:10.1016/j.heliyon.2022.e11409. https://pubmed.ncbi.nlm.nih.gov/36387495/
2. Feng, Chen, Li, Pingping, Liu, Pengtao, Li, Juan, Liu, Peijun. . LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway. In Cancer medicine, 13, e70448. doi:10.1002/cam4.70448. https://pubmed.ncbi.nlm.nih.gov/39618331/
3. Lamothe, Shawn M, Das, Damayantee, Wong, Anson A, Baronas, Victoria A, Kurata, Harley T. . Regulation of Kv1.2 Redox-Sensitive Gating by the Transmembrane Lectin LMAN2. In Function (Oxford, England), 5, . doi:10.1093/function/zqae041. https://pubmed.ncbi.nlm.nih.gov/39264045/
4. Zhang, Di, Ye, Liping, Hu, Shuang, Li, Chenxi, Zhu, Chengming. 2022. Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer. In Journal of immunology research, 2022, 7623654. doi:10.1155/2022/7623654. https://pubmed.ncbi.nlm.nih.gov/35707004/
5. Xiao, Sujian, Yu, Tong, Yang, Fulan, Yuan, Huozhong, Ni, Jun. 2025. LMAN2 interacts with HEATR3 to expedite HER2-positive breast cancer advancement and inflammation and Akt/ERK/NF-κB signaling. In Biochemistry and cell biology = Biochimie et biologie cellulaire, 103, 1-11. doi:10.1139/bcb-2024-0166. https://pubmed.ncbi.nlm.nih.gov/39772898/
6. Das, Damayantee, Lamothe, Shawn M, Wong, Anson A, Baronas, Victoria A, Kurata, Harley T. . Competitive modulation of KV1.2 gating by LMAN2 and Slc7a5. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 38, e70243. doi:10.1096/fj.202401737RR. https://pubmed.ncbi.nlm.nih.gov/39659243/
7. Suzuki, Masayoshi, Tezuka, Kenta, Handa, Takumi, Tano, Mitsutoshi, Uchida, Yasuo. 2022. Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients. In Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 42, 2134-2150. doi:10.1177/0271678X221111602. https://pubmed.ncbi.nlm.nih.gov/35766008/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
